story of the week
Cemiplimab Plus Chemotherapy vs Chemotherapy Alone for Advanced NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial
Nat. Med. 2022 Aug 25;[EPub Ahead of Print], M Gogishvili, T Melkadze, T Makharadze, D Giorgadze, M Dvorkin, K Penkov, K Laktionov, G Nemsadze, M Nechaeva, I Rozhkova, E Kalinka, C Gessner, B Moreno-Jaime, R Passalacqua, S Li, K McGuire, M Kaul, A Paccaly, RGW Quek, B Gao, F Seebach, DM Weinreich, GD Yancopoulos, I Lowy, G Gullo, P RietschelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.